Secondary sulfonamides as effective lactoperoxidase inhibitors

View/ Open
Access
info:eu-repo/semantics/openAccessDate
2017Author
Köksal, ZeynepKalın, Ramazan
Camadan, Yasemin
Usanmaz, Hande
Almaz, Züleyha
Gülçin, İlhami
Ğökçe, Taner
Gören, Ahmet Ceyhan
Özdemir, Hasan
Metadata
Show full item recordCitation
Köksal, Z., Kalın, R., Camadan, Y., Usanmaz, H., Almaz, Z., Gülçin, I., ... & Özdemir, H. (2017). Secondary sulfonamides as effective lactoperoxidase inhibitors. Molecules, 22(6), 793. Doi: 10.3390/molecules22060793Abstract
Secondary sulfonamides (4a–8h) incorporating acetoxybenzamide, triacetoxybenzamide,
hydroxybenzamide, and trihydroxybenzamide and possessing thiazole, pyrimidine, pyridine,
isoxazole and thiadiazole groups were synthesized. Lactoperoxidase (LPO, E.C.1.11.1.7), as a natural
antibacterial agent, is a peroxidase enzyme secreted from salivary, mammary, and other mucosal
glands. In the present study, the in vitro inhibitory effects of some secondary sulfonamide derivatives
(4a–8h) were examined against LPO. The obtained results reveal that secondary sulfonamide
derivatives (4a–8h) are effective LPO inhibitors. The Ki values of secondary sulfonamide derivatives
(4a–8h) were found in the range of 1.096 × 10−3
to 1203.83 µM against LPO. However, the most
effective inhibition was found for N-(sulfathiazole)-3,4,5-triacetoxybenzamide (6a), with Ki values of
1.096 × 10−3 ± 0.471 × 10−3 µM as non-competitive inhibition.